Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Myomo, Inc. (MYO : AMEX)
 
 • Company Description   
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.

Number of Employees: 195

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.89 Daily Weekly Monthly
20 Day Moving Average: 347,063 shares
Shares Outstanding: 38.64 (millions)
Market Capitalization: $34.31 (millions)
Beta: 1.39
52 Week High: $3.69
52 Week Low: $0.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 11.84% 4.98%
12 Week 16.90% 6.94%
Year To Date -2.42% -10.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
45 Blue Sky Dr. Suite 101
-
Burlington,MA 01803
USA		 ph: 617-996-9058
fax: -		 ir@myomo.com http://www.myomo.com
 
 • General Corporate Information   
Officers
Paul R. Gudonis - President; Chief Executive Officer and Chairman
David A. Henry - Chief Financial Officer
Thomas A. Crowley, Jr. - Director
Thomas F. Kirk - Director
Milton M. Morris - Director

Peer Information
Myomo, Inc. (BJCT)
Myomo, Inc. (CADMQ)
Myomo, Inc. (APNO)
Myomo, Inc. (UPDC)
Myomo, Inc. (IMTIQ)
Myomo, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 62857J201
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/10/26
Share - Related Items
Shares Outstanding: 38.64
Most Recent Split Date: 1.00 (0.03:1)
Beta: 1.39
Market Capitalization: $34.31 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.28 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.81
Price/Cash Flow: -
Price / Sales: 0.83
EPS Growth
vs. Year Ago Period: -12.50%
vs. Previous Quarter: -12.50%
Sales Growth
vs. Year Ago Period: 2.86%
vs. Previous Quarter: -10.92%
ROE
03/31/26 - -119.60
12/31/25 - -94.03
09/30/25 - -61.14
ROA
03/31/26 - -42.50
12/31/25 - -40.35
09/30/25 - -30.85
Current Ratio
03/31/26 - 2.73
12/31/25 - 3.30
09/30/25 - 2.49
Quick Ratio
03/31/26 - -
12/31/25 - 2.93
09/30/25 - 2.10
Operating Margin
03/31/26 - -38.20
12/31/25 - -37.52
09/30/25 - -28.86
Net Margin
03/31/26 - -36.69
12/31/25 - -38.05
09/30/25 - -28.86
Pre-Tax Margin
03/31/26 - -35.34
12/31/25 - -36.82
09/30/25 - -27.65
Book Value
03/31/26 - 0.23
12/31/25 - 0.30
09/30/25 - 0.39
Inventory Turnover
03/31/26 - 3.89
12/31/25 - 3.94
09/30/25 - 3.89
Debt-to-Equity
03/31/26 - 1.21
12/31/25 - 0.98
09/30/25 - 0.17
Debt-to-Capital
03/31/26 - 54.83
12/31/25 - 49.60
09/30/25 - 14.18
 

Powered by Zacks Investment Research ©